CCS Director Richard Greil among the most highly cited researcher in clinical medicine in 2022
Congratulations to Prof. Richard Greil - Head of the CCS - for being named by Clarivate/Web of Science one of the world's most highly...
top of page
CCS News
Search
- Jul 29, 2022
New FWF grant to Giorgia Nasi on Gamma/Delta T Cells in Cancer Therapy
Great success for Giorgia Nasi from the CCS research team of Iris Gratz. At its last meeting, the Austrian Science Fund (FWF) decided to...
40 views
- Nov 10, 2021
New publication of the Wessler lab on H. pylori infections in gastric cancer
The Wessler lab published new results on substrates of the Helicobacter pylori HtrA protease in epithelial cells in the context of...
20 views
- Nov 6, 2021
Kurt Zopf Prize Awarded to Iris Gratz
We are pleased to announce that our colleague and CCS member Iris Gratz (AG Tissue Immunity) has been awarded this year's Kurt Zopf Prize...
34 views
- Sep 30, 2021
Hypomethylating agents as preferred therapy for higher-risk CMML patients
A research team lead by CCS member Lisa Pleyer (image) and CCS director Richard Greil published data of a retrospective cohort study in...
34 views
- Sep 29, 2021
Breast cancer study published in The New England Journal of Medicine
A research consortium led by CCS director Prof. Richard Greil and Prof. Michael Gnant (Med. University Vienna) published results on the...
27 views
- Sep 8, 2021
CCS researchers identify new drug target for cancer therapy
CCS researchers led by the Aberger group in collaboration with 4SC biotech have identified the kinase CSNK1D as novel drug targets for...
72 views
- Mar 22, 2021
New FWF grant on NLRP3 signaling in AML awarded to CCS member Jutta Horejs-Hoeck
We are pleased to announce that the FWF approved in its meeting on March 8, 2021 the project proposal of Jutta Horejs-Hoeck to...
51 views
- Aug 13, 2020
CCS researchers identify immunosuppressive mechanisms in skin cancer development
CCS members of the University of Salzburg and the Salzburg Cancer Research Institute unravel the molecular and cellular mechanisms of how...
32 views
- Jul 27, 2020
CCS researchers provide new insights into oncogenic signals and mechanisms of cancer drug actions
Using data-driven phospho-proteomics approaches the CCS labs of Christian Huber and Fritz Aberger collaboratively determined the ...
12 views
- Jun 30, 2020
CCS researchers identify new cell adhesion mechanisms involved in AML pathogenesis
The Hartmann group in collaboration with other CCS researchers and international collaboration partners identified a novel mechanistic...
18 views
bottom of page